“aisling-capital” Archives

Entry Author Date Location
Versartis Lands $55,000,000 Series E Financing 02/18/14 San Francisco
Miramar Labs Secures $10,000,000 Series D Funding 02/13/14 San Francisco
ViewRay Lands $30,000,000 New Funding 12/17/13 Detroit Ann Arbor
ViewRay Secures $30,000,000 New Financing 12/17/13 Detroit Ann Arbor
Seragon Pharmaceuticals Obtains $30,000,000 Series A Financing 10/18/13 San Diego
Versartis Garners $20,000,000 Series D Financing Round 10/08/13 San Francisco
East Coast Life Sciences Roundup: Moderna, Inotek, Roche, & More 10/04/13 Boston
Loxo Oncology Lands $33,000,000 Series A Funding Round 10/04/13 New York
5 Things Biotechs Should Do to Take Advantage of The Boom 09/05/13 New York
Biotech VCs, Stung by Startup Returns, Elbow into Royalty Financing 08/16/13 Boston
Esperion Therapeutics Secures $33,000,000 New Funding Round 04/25/13 Detroit Ann Arbor
T2 Biosystems Obtains $40,000,000 Series E Funding 03/28/13 Boston
Versartis Secures $25,000,000 Series C Funding 01/15/13 San Francisco
Mayleben Ends Short-Lived Retirement to Lead Esperion 01/04/13 Detroit Ann Arbor
San Diego Life Sciences Roundup: Deals at MEI Pharma, Auspex, Ambit 11/09/12 San Diego
San Diego’s Ambit Biosciences Raises $25M to Advance Leukemia Drug 11/06/12 San Diego
Ambit Biosciences Obtains $50,000,000 New Funding 11/06/12 San Diego
Can New York Take on Boston, California as a Biotech Hub? 10/11/12 New York
San Diego Life Sciences Roundup: Regulus, Aragon, Cytori, & More 10/05/12 San Diego
Reinventing Biotech’s Biz Model for NY: Issues for Our Oct. 4 Event 10/01/12 New York
Aragon Pharmaceuticals Receives $49,999,988 Series D Round 09/26/12 San Diego
Almost Time for Face Time with Sam Waksal, Kevin Kinsella, and More 09/20/12 New York
NYC Bio Luminaries to Gather Oct. 4th for Xconomy Xchange 09/04/12 New York
An Insider’s View on Raising Money from Life Sciences VCs 08/21/12 New York
Fall Xconomy Xchange to Focus on Reinventing Biotech for the Big Apple 07/31/12 New York
Who’s Still Active Among the Early-Stage Biotech VCs? 07/02/12 National
San Diego’s Aragon Raises $42 Million, Targets Hormone-Driven Cancers 03/06/12 San Diego
Aragon Pharmaceuticals Obtains $42,000,000 Series C Financing Round 03/06/12 San Diego
New York’s Venture Emergence: The Photos 02/03/12 New York
Global Healthcare 01/18/12 New York
Page 2 of 3 « previous page · next page »